Biotechnology

Biotechnology is the integration of natural sciences and engineering to develop applications from organisms, cells, and molecular analogs for products and services. It harnesses cellular and biomolecular processes, developed over millennia in fields like agriculture and medicine, to create technologies that improve human life and the health of the planet. The field is fundamentally interdisciplinary, drawing from molecular biology, biochemistry, cell biology, and genetics.

History

The earliest applications, often termed traditional biotechnology, date back thousands of years, including the use of yeast for bread-making and fermentation for beer and wine in ancient Mesopotamia and Egypt. The 19th century brought pivotal discoveries, such as Louis Pasteur's work on microbial fermentation and Gregor Mendel's principles of heredity. The modern era was catalyzed in 1953 by the elucidation of the DNA double helix structure by James Watson and Francis Crick, followed by the development of recombinant DNA technology in the 1970s by researchers like Herbert Boyer and Stanley Cohen. This enabled the first genetically modified organism and launched companies like Genentech, founded by Robert Swanson and Herbert Boyer.

Core techniques and applications

Fundamental techniques include DNA sequencing, pioneered by Frederick Sanger and later advanced by projects like the Human Genome Project, and polymerase chain reaction (PCR), invented by Kary Mullis. Genetic engineering allows for the direct manipulation of an organism's genome using tools like CRISPR-Cas9, developed by researchers including Emmanuelle Charpentier and Jennifer Doudna. Key applications span producing therapeutic proteins like insulin in Escherichia coli, developing monoclonal antibodies for treating cancer and autoimmune diseases, and creating genetically modified crops with traits such as pest resistance, exemplified by products from Monsanto and Syngenta.

Major subfields

* Medical Biotechnology (Red Biotechnology): Focuses on human health, encompassing pharmacogenomics, gene therapy trials like those for severe combined immunodeficiency (SCID), and the production of vaccines, including mRNA vaccines for COVID-19 developed by Pfizer–BioNTech and Moderna. * Agricultural Biotechnology (Green Biotechnology): Aims to enhance crop yield and sustainability through plant breeding, Bt crops, and innovations like Golden Rice, developed by Ingo Potrykus and Peter Beyer. * Industrial Biotechnology (White Biotechnology): Uses enzymes and microorganisms for manufacturing, such as producing biofuels from algae or cellulose, and bioplastics by companies like Novozymes and DuPont. * Environmental Biotechnology (Grey Biotechnology): Applies biological processes to remediation, including bioremediation of oil spills and wastewater treatment using specialized microbes. * Bioinformatics and Computational Biology: Involves analyzing biological data using tools from institutions like the National Center for Biotechnology Information (NCBI) and the European Molecular Biology Laboratory (EMBL).

Ethical, legal, and social implications

The field raises profound questions, debated by bodies like the Nuffield Council on Bioethics and the UNESCO International Bioethics Committee. Key issues include the ethics of human germline editing, as highlighted by the case of He Jiankui, and concerns over genetic discrimination, addressed in laws like the Genetic Information Nondiscrimination Act (GINA) in the United States. The patenting of life forms, established in the Diamond v. Chakrabarty Supreme Court case, and issues of biopiracy involving resources from biodiversity-rich regions like the Amazon rainforest are also contentious.

Regulation and safety

Governance frameworks vary globally to ensure safety and efficacy. In the United States, the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) oversee products, while the Environmental Protection Agency (EPA) regulates environmental releases. The European Union operates under strict directives from the European Medicines Agency (EMA) and the European Food Safety Authority (EFSA). International agreements, such as the Cartagena Protocol on Biosafety under the Convention on Biological Diversity, govern the transboundary movement of living modified organisms.

Economic impact and industry

It is a major global economic driver, with hubs in Silicon Valley, Boston, and Cambridge, England. Leading firms include Amgen, Gilead Sciences, and Roche. The sector attracts significant investment from venture capital firms and public markets, with milestones like the IPO of Moderna. It also fuels growth in related sectors like companion diagnostics and contract research organizations (CROs) such as IQVIA and Charles River Laboratories. National initiatives, like China's strategic investments and the Biotechnology Industry Organization (BIO) in the U.S., underscore its geopolitical importance.

Category:Biotechnology